Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
These products are sold for research purposes and require users to take responsibility for their own decisions regarding use
Stick to your provider's template for your individual plan
State of Charge (SOC) (%): Represents the percentage of the battery's total capacity that is charged
Monthly $319/mo 12-Week $249/mo 52-Week $199/mo Visits, meds, coaching & shipping all included Dual-agonist (GLP-1 + GIP) faster avg loss NPI-verified compounding pharmacy 20.9% body weight at 15 mg in trials Free no card required Learn more about this treatment Safety information Clinical-trial results for semaglutide (STEP-1, NEJM 2021) and tirzepatide (SURMOUNT-1, NEJM 2022) the active medications in REMEVi protocols, not REMEVi outcomes or guarantees
US$ 21.46
US$ 28.86
US$ 28.35
US$ 29.57
